Abstract:Jingmei Huang, 1, &ast Lianshan Guo, 1, &ast Xiaoxiao Huang, 1 Xiaoping Yu, 2 Liqiao Lin, 1 Xinlin Jiang, 3 Zhihao Bai, 4 Zhengzhao Li 1 1 Department of Emergency, The Second Affiliated Hospital of Guangxi Medical University, Nanning, Guangxi, 530007, People's Republic of China; 2 Department of Radiology, The Second Affiliated Hospital of Guangxi Medical University, Nanning, Guangxi, 530007, People's Republic of China; 3 Department of General Medicine, The Second Affiliated Hospital of Guangxi Medical University, Nanning, Guangxi, 530007, People's Republic of China; 4 College of Chemistry and Chemical Engineering, Guangxi University, Nanning, Guangxi, 530004, People's Republic of China &astThese authors contributed equally to this work Correspondence: Zhengzhao Li, Department of Emergency, The Second Affiliated Hospital of Guangxi Medical University, Nanning, Guangxi, 530007, People's Republic of China, Email Zhihao Bai, College of Chemistry and Chemical Engineering, Guangxi University, Nanning, Guangxi, 530004, People's Republic of China, Email Purpose: The study aimed to address the non-specific toxicity of cytotoxins (CTX) in liver cancer treatment and explore their combined application with the photosensitizer Ce6, co-loaded into carbonized Zn/Co bimetallic organic frameworks. The goal was to achieve controlled CTX release and synergistic photodynamic therapy, with a focus on evaluating anti-tumor activity against human liver cancer cell lines (Hep G2). Methods: Purified cobra cytotoxin (CTX) and photosensitizer Ce6 were co-loaded into carbonized Zn/Co bimetallic organic frameworks, resulting in RGD-PDA@C-ZIF@(CTX+Ce6). The formulation was designed with surface-functionalization using polydopamine and tumor-penetrating peptide RGD. This approach aimed to facilitate controlled CTX release and enhance the synergistic effect of photodynamic therapy. The accumulation of RGD-PDA@C-ZIF@(CTX+Ce6) at tumor sites was achieved through RGD's active targeting and the enhanced permeability and retention (EPR) effect. In the acidic tumor microenvironment, the porous structure of the metal-organic framework disintegrated, releasing CTX and Ce6 into tumor cells. Results: Experiments demonstrated that RGD-PDA@C-ZIF@(CTX+Ce6) nanoparticles, combined with near-infrared laser irradiation, exhibited optimal anti-tumor effects against human liver cancer cells. The formulation showcased heightened anti-tumor activity without discernible systemic toxicity. Conclusion: The study underscores the potential of utilizing metal-organic frameworks as an efficient nanoplatform for co-loading cytotoxins and photodynamic therapy in liver cancer treatment. The developed formulation, RGD-PDA@C-ZIF@(CTX+Ce6), offers a promising avenue for advancing the clinical application of cytotoxins in oncology, providing a solid theoretical foundation for future research and development. Keywords: metal-organic frameworks, cytotoxins, photodynamic therapy, liver cancer Liver cancer stands as one of the most prevalent and lethal malignancies globally. As per 2020 statistics, it ranks sixth worldwide, asserting its place among the most common cancer types and holds the third position in cancer-related mortality. 1 The carcinoma's highly invasive nature, coupled with an absence of early discernible symptoms, renders early diagnosis and intervention profoundly challenging. While conventional oncological treatments have seen some advancements, the therapeutic outcomes for liver cancer, hindered by tumor heterogeneity and drug resistance, remain suboptimal. 2,3 Thus, there's an urgent call to pioneer novel therapeutic strategies to enhance the survival rates and quality of life for patients afflicted with this condition. Nanomedicine, as an emergent therapeutic strategy, has garnered considerable attention in the realm of oncology in recent years. The distinct properties of nanomaterials position them as promising vectors capable of concurrently ferrying multiple therapeutic agents, orchestrating a multifaceted assault on tumors. 4–6 The Zn/Co metal-organic frameworks represent a class of nanomaterials endowed with exceptional modularity and multifunctionality. Their expansive surface area and porous architecture offer an optimal platform for combinatorial drug therapy. These frameworks adeptly adsorb and accommodate various drug molecules, ensuring precise drug deployment within the acidic milieu of tumor environments. 7 Cobratoxin (CTX) is an alkaline cationic polypeptide, isolated from cobra venom, spanning 60–63 amino acids and possessing a molecular weight between 6–7 -Abstract Truncated-

Fluorescent Imaging-Guided Chemo- and Photodynamic Therapy of Hepatocellular Carcinoma with HCPT@NMOFs-RGD Nanocomposites

Targeted Multifunctional Nanoplatform for Imaging-Guided Precision Diagnosis and Photothermal/Photodynamic Therapy of Orthotopic Hepatocellular Carcinoma

Multimodal Imaging-Guided Synergistic Photodynamic Therapy Using Carbonized Zn/Co Metal-Organic Framework Loaded with Cytotoxin Against Liver Cancer

Fabrication of Glyco‐Metal‐Organic Frameworks for Targeted Interventional Photodynamic/Chemotherapy for Hepatocellular Carcinoma through Percutaneous Transperitoneal Puncture

Glucose-Regulated Protein 78 Targeting ICG and DOX Loaded Hollow Fe3O4 Nanoparticles for Hepatocellular Carcinoma Diagnosis and Therapy

A Nanoreactor Based on Metal–Organic Frameworks With Triple Synergistic Therapy for Hepatocellular Carcinoma

All-in-one hollow nanoformulations enabled imaging-guided Mn-amplified chemophototherapy against hepatocellular carcinoma

A Hepatocellular Carcinoma Targeting Nanostrategy with Hypoxia-Ameliorating and Photothermal Abilities that, Combined with Immunotherapy, Inhibits Metastasis and Recurrence

Copper-Doped Platinum/Metal-Organic Framework Nanostructures for Imaging-Guided Photothermal and H 2 O 2 Self-Supplying Photodynamic/Photothermal/Chemodynamic Therapy

Biodegradable Hypocrellin B nanoparticles coated with neutrophil membranes for hepatocellular carcinoma photodynamics therapy effectively via JUNB/ROS signaling

Palladium Nanocrystals‐Engineered Metal–Organic Frameworks for Enhanced Tumor Inhibition by Synergistic Hydrogen/Photodynamic Therapy

Laser-Induced Combinatorial Chemotherapeutic, Chemodynamic, and Photothermal Therapy for Hepatocellular Carcinoma Based on Oxaliplatin-Loaded Metal–Organic Frameworks

An inorganic-organic-polymeric nanovehicle for targeting delivery of doxorubicin: Rational assembly, pH-stimulus release, and dual hyperthermia/chemotherapy of hepatocellular carcinoma

Engineering Phototheranostic Nanoscale Metal-Organic Frameworks for Multimodal Imaging-Guided Cancer Therapy

PEGylated Mbpei-Rgo Nanocomposites Facilitate Hepotocarcinoma Treatment Combining Photothermal Therapy and Chemotherapy.

Nuclear-targeted smart nanoplatforms featuring double-shell hollow mesoporous copper sulfide coated with manganese dioxide synergistically potentiate chemotherapy and immunotherapy in hepatocellular carcinoma cells

Targeting Chemophotothermal Therapy of Hepatoma by Gold Nanorods/graphene Oxide Core/shell Nanocomposites.

A metal-organic framework (MOF) built on surface-modified Cu nanoparticles eliminates tumors via multiple cascading synergistic therapeutic effects

Chemo-photodynamic therapy with light-triggered disassembly of theranostic nanoplatform in combination with checkpoint blockade for immunotherapy of hepatocellular carcinoma

All-in-One HN@Cu-MOF nanoparticle with Enhanced Reactive Oxygen Species Generation and GSH Depletion for Effective Tumor Treatment

An Enzyme-responsive Porphyrin Metal-organic Framework Nanosystem for Targeted and Enhanced Synergistic Cancer Photo-chemo Therapy